We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
AB InBev
BUD
$158B
| $33.9M | 0.12% |
301,607
+43,321
| +17% | +$4.8M |
|
|
VIAB
177
DELISTED
Viacom Inc. Class B
VIAB
| $33.8M | 0.12% |
449,429
-407,149
| -48% | -$29.8M |
|
178
Monster Beverage
MNST
$91.4B
| $33.6M | 0.12% |
1,857,936
-553,128
| -23% | -$9.54M |
|
179
RTX Corp
RTX
$287B
| $33.4M | 0.12% |
461,055
+311,405
| +208% | +$21.2M |
|
180
Brown-Forman Class B
BF.B
$12B
| $32.6M | 0.11% |
1,161,231
-258,991
| -18% | -$7.49M |
|
181
Edwards Lifesciences
EW
$47.6B
| $32.4M | 0.11% |
1,527,300
-996,048
| -39% | -$20M |
|
|
WNR
182
DELISTED
Western Refining Inc
WNR
| $32.3M | 0.11% |
+855,581
| New | +$35.4M |
|
183
Prudential Financial
PRU
$41.7B
| $31.9M | 0.11% |
352,155
+212
| +0.1% | +$18.2K |
|
184
Sensata Technologies
ST
$6.65B
| $31.6M | 0.11% |
602,433
+65,793
| +12% | +$3.19M |
|
185
Delek US
DK
$3.87B
| $31.3M | 0.11% |
+1,146,901
| New | +$34.7M |
|
186
Citizens Financial Group
CFG
$30.4B
| $31.1M | 0.11% |
1,250,000
+550,000
| +79% | +$13.1M |
|
|
SIRO
187
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $31M | 0.11% |
355,000
+45,000
| +15% | +$3.72M |
|
188
Corning
GLW
$126B
| $31M | 0.11% |
1,350,000
+230,000
| +21% | +$4.68M |
|
189
Copa Holdings
CPA
$5.56B
| $30.8M | 0.11% |
297,629
+240,821
| +424% | +$25.6M |
|
190
H&R Block
HRB
$5.18B
| $30.8M | 0.11% |
914,026
-892
| -0.1% | -$28.6K |
|
|
CELG
191
DELISTED
Celgene Corp
CELG
| $30.8M | 0.11% |
+275,188
| New | +$29M |
|
|
GGP
192
DELISTED
GGP Inc.
GGP
| $30.5M | 0.11% |
1,085,728
-58,114
| -5% | -$1.51M |
|
193
TSMC
TSM
$2.09T
| $30.5M | 0.11% |
1,363,630
+63,700
| +5% | +$1.39M |
|
|
PAY
194
DELISTED
Verifone Systems Inc
PAY
| $30.5M | 0.11% |
818,912
+215,828
| +36% | +$7.6M |
|
|
IPG
195
DELISTED
Interpublic Group of Companies
IPG
| $30.3M | 0.1% |
1,461,163
+583,715
| +67% | +$11.2M |
|
196
KLA
KLAC
$275B
| $30.2M | 0.1% |
4,300,000
-700,000
| -14% | -$5.17M |
|
|
NORD
197
DELISTED
Nord Anglia Education, Inc.
NORD
| $29.7M | 0.1% |
1,555,552
| – | – |
|
198
Xerox
XRX
$337M
| $29.6M | 0.1% |
811,230
+223,204
| +38% | +$7.87M |
|
199
AstraZeneca
AZN
$263B
| $29.5M | 0.1% |
418,971
-498
| -0.1% | -$35.7K |
|
200
Eastman Chemical
EMN
$7.8B
| $29M | 0.1% |
381,760
-50,059
| -12% | -$3.96M |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.